|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2024
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/28643
Title: | Management of postpartum hemorrhage |
Authors: | Doncilă, Ilinca |
Issue Date: | 2024 |
Publisher: | Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova |
Citation: | DONCILĂ, Ilinca. Management of postpartum hemorrhage. In: MedEspera: the 10th Intern. Medical Congress for Stud. and Young Doctors, 24-27 April 2024: abstract book. Chișinău, 2024, p. 227. ISBN 978-9975-3544-2-4. |
Abstract: | Introduction. Postpartum hemorrhage (PPH) is defined as a blood loss from the genital tract of ≥500 mL associated with vaginal delivery or greater than 1000 mL following cesarean section, which requires emergency hysterectomy in severe cases. PH is classified as Primary if bleeding occurs within the first 24 h following delivery of the fetus. Secondary PPH occurs between 24 h and 12 weeks post-delivery. According to WHO, each year about 14 million women experience postpartum hemorrhage resulting in about 70.000 maternal deaths globally Aim of study. Review of the risk factors and management of hemorrhage after delivery. Methods and materials. Current review is based on articles published in the online databases as FIGO, PubMed, Medscape, mdpi.com, ScienceDirect using the Key words: “ postpartum hemorrhage”, “maternal morbidity ”, “bleeding after childbirth”, “retained placenta” . Results. This birth complication affects 2–4% of vaginal and 6% of cesarean deliveries. Common causes include uterine atony, retained placenta, trauma and coagulopathy. Therefore, women experiencing postpartum hemorrhage are vulnerable to hemorrhagic shock, blood transfusion, infertility secondary to hysterectomy. The effective management of PPH requires prompt recognition. Uterine atony causes 70-80% of PPH. Atony is suspected first and requires immediate medical intervention including: uterine massage, uterotonics (misoprostol, oxytocin, methylergometrin), Bakri ballon, tranexamic acid, intravenous fluids, B-lynch suture. To prevent PPH, a uterotonic drug is administered during the 3rd stage of labor in all births. Retained placental tissue is a cause which occurs in 1–3% of deliveries and increases the incidence of PPH by 3.5 times. Genital tract trauma accounts for 15% of cases. Over 85% of women who have a vaginal delivery will sustain perineal trauma. Performing examination of the genital tract is necessary to identify any trauma to the cervix, vagina or perineum to prevent significant blood loss. Coagulation disorders, both inherited and acquired, are reported in approximately 1% of PPH. Identification and correction of any coagulopathy could improve the outcome. Conclusion. Postpartum hemorrhage affects 1% to 10% of pregnancies. Taking the above information into consideration, identification of risk factors antenatally, suitable management of the 3rd stage of labor, appropriate patient monitoring and hemostatic interventions based on protocols are important, because the postpartum hemorrhage is the direct cause of mortality, accounting for 27.1% of maternal deaths worldwide. ≥500 mL associated with vaginal delivery or greater than 1000 mL following cesarean section, which requires emergency hysterectomy in severe cases. PH is classified as Primary if bleeding occurs within the first 24 h following delivery of the fetus. Se condary PPH occurs between 24 h and 12 weeks post-delivery. According to WHO, each year about 14 million women experience postpartum hemorrhage resulting in about 70.000 maternal deaths globally Aim of study. Review of the risk factors and management of hemorrhage after delivery. Methods and materials. Current review is based on articles published in the online dat abases as FIGO, PubMed, Medscape, mdpi.com, ScienceDirect using the Ke y words: “ postpartum hemorrhage”, “maternal morbidity ”, “bleeding after childbi rth”, “retained placenta” . Results. This birth complication affects 2–4% of vaginal and 6% of c esarean deliveries. Common causes include uterine atony, retained placenta, trauma an d coagulopathy. Therefore, women experiencing postpartum hemorrhage are vulnerable to hemorrha gic shock, blood transfusion, infertility secondary to hysterectomy. The effective man agement of PPH requires prompt recognition. Uterine atony causes 70-80% of PPH. Atony is suspect ed first and requires immediate medical intervention including: uterine massage, uterotonics (misoprostol, oxytocin, methylergometrin), Bakri ballon, tranexamic acid, intraven ous fluids, B-lynch suture. To prevent PPH, a uterotonic drug is administered during the 3rd stage of la bor in all births. Retained placental tissue is a cause which occurs in 1–3% of deliveries and increa ses the incidence of PPH by 3.5 times. Genital tract trauma accounts for 15% of cases. Ove r 85% of women who have a vaginal delivery will sustain perineal trauma. Performing examination of the genital tract is necessary to identify any trauma to the cervix, vagina or perineum to pr event significant blood loss. Coagulation disorders, both inherited and acquired, are reported in approxi mately 1% of PPH. Identification and correction of any coagulopathy could improve the outco me. Conclusion. Postpartum hemorrhage affects 1% to 10% of pregnancies. Taking the above information into consideration, identification of ris k factors antenatally, suitable management of the 3rd stage of labor, appropriate patient monitoring and h emostatic interventions based on protocols are important, because the postpartum hemorrhage i s the direct cause of mortality, accounting for 27.1% of maternal deaths worldwide. |
metadata.dc.relation.ispartof: | MedEspera: The 10th International Medical Congress for Students and Young Doctors, 24-27 April 2024, Chișinău, Republic of Moldova |
URI: | https://medespera.md/en/books?page=10 http://repository.usmf.md/handle/20.500.12710/28643 |
ISBN: | 978-9975-3544-2-4 |
Appears in Collections: | MedEspera 2024
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|